{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T14:55:17Z","timestamp":1763909717571,"version":"3.45.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,23]]},"DOI":"10.7759\/cureus.97557","type":"journal-article","created":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T14:52:27Z","timestamp":1763909547000},"source":"Crossref","is-referenced-by-count":0,"title":["Bilateral Central Serous Chorioretinopathy Associated With Tuberculosis in a Female Patient"],"prefix":"10.7759","author":[{"given":"William E","family":"Holmes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sriharanathan","family":"Poopalaratnam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-021-01808-3","article-title":"Pathophysiology of central serous chorioretinopathy: a literature review with quality assessment","volume":"36","author":"Kanda P","year":"2022","unstructured":"Kanda P, Gupta A, Gottlieb C, Karanjia R, Coupland SG, Bal MS. Pathophysiology of central serous chorioretinopathy: a literature review with quality assessment. Eye (Lond). 2022, 36:941-62. 10.1038\/s41433-021-01808-3","journal-title":"Eye (Lond)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/ceo.14201","article-title":"Central serous chorioretinopathy: a review","volume":"51","author":"Fung AT","year":"2023","unstructured":"Fung AT, Yang Y, Kam AW. Central serous chorioretinopathy: a review. Clin Exp Ophthalmol. 2023, 51:243-70. 10.1111\/ceo.14201","journal-title":"Clin Exp Ophthalmol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-023-02509-9","article-title":"Randomized controlled trials in central serous chorioretinopathy: a review","volume":"37","author":"Singh SR","year":"2023","unstructured":"Singh SR, Got\u00e9 JT, Chhablani J. Randomized controlled trials in central serous chorioretinopathy: a review. Eye (Lond). 2023, 37:3306-12. 10.1038\/s41433-023-02509-9","journal-title":"Eye (Lond)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/tjosr.tjosr_163_20","article-title":"Central serous chorioretinopathy following intravenous steroid therapy for retrobulbar optic neuritis - \u201ctreatment dilemma\u201d - case report and review of literature","volume":"59","author":"Mohan R","year":"2021","unstructured":"Mohan R, Arthi M, Basker A, Sivakumar P. Central serous chorioretinopathy following intravenous steroid therapy for retrobulbar optic neuritis - \u201ctreatment dilemma\u201d - case report and review of literature. TNOA J Ophthalmic Sci Res. 2021, 59:376-8. 10.4103\/tjosr.tjosr_163_20","journal-title":"TNOA J Ophthalmic Sci Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4103\/jcor.jcor_37_24","article-title":"Overview of latent tuberculosis-related central serous chorioretinopathy: review and case report","volume":"12","author":"Shukla R","year":"2024","unstructured":"Shukla R, Mishra AK, Garg P, Singh SP, Shrinkal. Overview of latent tuberculosis-related central serous chorioretinopathy: review and case report. J Clin Ophthalmol Res. 2024, 12:323-6. 10.4103\/jcor.jcor_37_24","journal-title":"J Clin Ophthalmol Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.15761\/NFO.1000254","article-title":"Bilateral chronic central serous chorioretinopathy associated with IGRA latent tuberculosis infection: a case report and review","volume":"6","author":"Kavanaugh AS","year":"2020","unstructured":"Kavanaugh AS, Shaukat BA, Pan JT, Langford MP. Bilateral chronic central serous chorioretinopathy associated with IGRA latent tuberculosis infection: a case report and review. New Front Ophthalmol. 2020, 6:10. 10.15761\/NFO.1000254","journal-title":"New Front Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.12669\/pjms.35.6.990","article-title":"Effect of altering the regime of oral rifampicin therapy in the treatment of persistent central serous chorioretinopathy","volume":"35","author":"Loya H","year":"2019","unstructured":"Loya H, Ghoghari H, Rizvi SF, Khan A. Effect of altering the regime of oral rifampicin therapy in the treatment of persistent central serous chorioretinopathy. Pak J Med Sci. 2019, 35:1687-90. 10.12669\/pjms.35.6.990","journal-title":"Pak J Med Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-015-2989-z","article-title":"Oral rifampin treatment for longstanding chronic central serous chorioretinopathy","volume":"254","author":"Shulman S","year":"2016","unstructured":"Shulman S, Goldenberg D, Schwartz R, et al.. Oral rifampin treatment for longstanding chronic central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol. 2016, 254:15-22. 10.1007\/s00417-015-2989-z","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2011-300183","article-title":"Oral rifampin utilisation for the treatment of chronic multifocal central serous retinopathy","volume":"96","author":"Steinle NC","year":"2012","unstructured":"Steinle NC, Gupta N, Yuan A, Singh RP. Oral rifampin utilisation for the treatment of chronic multifocal central serous retinopathy. Br J Ophthalmol. 2012, 96:10-3. 10.1136\/bjophthalmol-2011-300183","journal-title":"Br J Ophthalmol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.22271\/27081494.2025.v7.i1f.181","article-title":"Central serous chorioretinopathy secondary to latent tuberculosis in a hypertensive patient: a case report","volume":"7","author":"Karbhari A","year":"2025","unstructured":"Karbhari A, Mutalik D, Bubhanale S, Maniyar F, Patel M, Wani R. Central serous chorioretinopathy secondary to latent tuberculosis in a hypertensive patient: a case report. Int J Case Rep Surg. 2025, 7:295-7. 10.22271\/27081494.2025.v7.i1f.181","journal-title":"Int J Case Rep Surg"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.TNMI7-0001-2016","article-title":"Ocular tuberculosis","volume":"4","author":"Albert DM","year":"2016","unstructured":"Albert DM, Raven ML. Ocular tuberculosis. Microbiol Spectr. 2016, 4:10.1128\/microbiolspec.TNMI7-0001-2016","journal-title":"Microbiol Spectr"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_864_16","article-title":"Retina and the tubercle Bacillus: four decades of our journey and current understanding","volume":"65","author":"Venkatesh P","year":"2017","unstructured":"Venkatesh P. Retina and the tubercle Bacillus: four decades of our journey and current understanding. Indian J Ophthalmol. 2017, 65:122-7. 10.4103\/ijo.IJO_864_16","journal-title":"Indian J Ophthalmol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2016-216471","article-title":"Central serous chorioretinopathy secondary to tuberculosis: cause or coincidence","volume":"2017","author":"Khan P","year":"2017","unstructured":"Khan P, Khan L, Anjum N, Saxena N. Central serous chorioretinopathy secondary to tuberculosis: cause or coincidence. BMJ Case Rep. 2017, 2017:10.1136\/bcr-2016-216471","journal-title":"BMJ Case Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/ICB.0b013e3182235561","article-title":"Chronic central serous chorioretinopathy responsive to rifampin","volume":"6","author":"Ravage ZB","year":"2012","unstructured":"Ravage ZB, Packo KH, Creticos CM, Merrill PT. Chronic central serous chorioretinopathy responsive to rifampin. Retin Cases Brief Rep. 2012, 6:129-32. 10.1097\/ICB.0b013e3182235561","journal-title":"Retin Cases Brief Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bcr.11.2011.5231","article-title":"Atypical central serous retinopathy in a patient with latent tuberculosis","volume":"2012","author":"Vayalambrone D","year":"2012","unstructured":"Vayalambrone D, Ivanova T, Misra A. Atypical central serous retinopathy in a patient with latent tuberculosis. BMJ Case Rep. 2012, 2012:10.1136\/bcr.11.2011.5231","journal-title":"BMJ Case Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000004478","article-title":"Incidence, management, and outcomes of eyes with comorbid active uveitis and central serous chorioretinopathy","author":"Nguyen MK","year":"2025","unstructured":"Nguyen MK, Momenaei B, Yu J, et al.. Incidence, management, and outcomes of eyes with comorbid active uveitis and central serous chorioretinopathy. Retina. 2025, 10.1097\/IAE.0000000000004478","journal-title":"Retina"},{"key":"ref17","article-title":"Rifampin for treatment of central serous chorioretinopathy","volume":"52","author":"Ravage ZB","year":"2011","unstructured":"Ravage ZB, Packo KH. Rifampin for treatment of central serous chorioretinopathy. Invest Ophthalmol Vis Sci. 2011, 52:2137.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.12669\/pjms.325.10755","article-title":"Effect of half adult dose of oral rifampicin (300mg) in patients with idiopathic central serous chorioretinopathy","volume":"32","author":"Khan MS","year":"2016","unstructured":"Khan MS, Sameen M, Lodhi AA, Ahmed M, Ahmed N, Kamal M, Junejo SA. Effect of half adult dose of oral rifampicin (300mg) in patients with idiopathic central serous chorioretinopathy. Pak J Med Sci. 2016, 32:1158-63. 10.12669\/pjms.325.10755","journal-title":"Pak J Med Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-200312000-00009","article-title":"Subretinal fluid analysis in the diagnosis of choroidal tuberculosis","volume":"23","author":"Salman A","year":"2003","unstructured":"Salman A, Parmar P, Rajamohan M, Thomas PA, Jesudasan N. Subretinal fluid analysis in the diagnosis of choroidal tuberculosis. Retina. 2003, 23:796-9. 10.1097\/00006982-200312000-00009","journal-title":"Retina"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/424379-bilateral-central-serous-chorioretinopathy-associated-with-tuberculosis-in-a-female-patient","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T14:52:28Z","timestamp":1763909548000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/424379-bilateral-central-serous-chorioretinopathy-associated-with-tuberculosis-in-a-female-patient"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,23]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.97557","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,23]]}}}